Episode 55: What is Adaptive Trial Design?
from QCast: Data-Driven Dialogue in Drug Development Hosted by Quanticate
In this QCast episode, Jullia and Tom examine how adaptive trial design allows pre-specified changes to a clinical trial using accumulating interim data. They look at common adaptations, including early stopping, sample size re-estimation and dose selection, while also addressing the statistical, operational and governance controls needed to protect trial integrity. Key Takeaways Adaptive changes must be planned in advance, with clear decision rules, timing and analysis methods. Recruitment speed, endpoint timing and data readiness can determine whether an adaptation is useful in practice. Statistical simulation, operational testing and controlled access to interim results all need to be considered before the first live analysis. 🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. 📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. 🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & Management Biostatistics & Statistical Consultancy Statistical Programming & PK/PD Analysis Medical Writing & Pharmacovigilance Regulatory & Submission Support AI & Automation Post-Marketing Safety & Real-World Data Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Embed this episode
What this episode covers
In this QCast episode, Jullia and Tom examine how adaptive trial design allows pre-specified changes to a clinical trial using accumulating interim data. They look at common adaptations, including early stopping, sample size re-estimation and dose selection, while also addressing the statistical, operational and governance controls needed to protect trial integrity. Key Takeaways Adaptive changes must be planned in advance, with clear decision rules, timing and analysis methods.Recruitment sp...
No transcript yet.